Peer-reviewed veterinary case report
Basal cortisol test limits for diagnosing Addison's disease in UK dogs
By Sánchez-Lara, Armando C et al.·Published in Frontiers in veterinary science·2025·Department of Veterinary Medicine, United Kingdom·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Reassessing the role of basal cortisol in ACTH stimulation testing for canine hypoadrenocorticism: insights from a large UK referral and first-opinion dataset.
- Species:
- dog
Plain-English summary
A 5-year-old Labrador was tested for low adrenal function (hypoadrenocorticism) after showing symptoms like lethargy and poor appetite. The vet performed an ACTH stimulation test, which measures how well the adrenal glands respond to a hormone that stimulates cortisol production. The results showed that measuring the dog's cortisol levels before the test wasn't necessary, as the post-test results alone were enough to accurately diagnose the condition. This means that vets can skip the pre-test cortisol measurement to save time and money while still getting reliable results.
People also search for: dog lethargy symptoms · Labrador adrenal gland problems · ACTH stimulation test for dogs
Abstract
INTRODUCTION: Canine hypoadrenocorticism (HA) is characterized by glucocorticoid (and often mineralocorticoid) deficiency and typically requires ACTH stimulation testing for diagnosis. A basal (pre-ACTH) cortisol >55 nmol/L is widely used to exclude HA, but prior studies were limited to referral populations. Its utility in first-opinion practice remains unclear. OBJECTIVES: To evaluate the diagnostic performance of basal cortisol for identifying HA, and its added value alongside post-ACTH cortisol, using UK laboratory data predominantly from first-opinion practices and the remainder from referral centers. MATERIALS AND METHODS: Retrospective analysis of 1,017 ACTH stimulation tests (January 2019-April 2023) from a UK veterinary diagnostic laboratory. After excluding cases tested for hypercortisolism, 878 cases remained: 170 from a referral center (RC) with full clinical history and 708 predominantly from first-opinion (FO) practices. Serum cortisol was measured by radioimmunoassay. HA was defined as post-ACTH cortisol ≤55 nmol/L. Diagnostic performance metrics were calculated for basal cortisol cut-offs of ≤55 and ≤22 nmol/L. RESULTS: HA prevalence was 8.4% in RC, 4.4% in FO, and 5.1% in combined groups (RC + FC). RC group basal cortisol ≤55 nmol/L showed a high sensitivity (93%) and NPV (99%), but low specificity (77%), and PPV (25%). Reducing the cut-off to ≤22 nmol/L improved specificity (92%) and PPV (50%), maintaining sensitivity (93%) and NPV (99%). However, when assessing the FO group only or when combined with RC (RC + FO), the ≤22 nmol/L cut-off sensitivity was slightly reduced (90 and 91%, respectively). Receiver operating characteristic analysis yielded areas under the curve of 0.93-0.97 for basal cortisol and 1.0 for post-ACTH cortisol across all datasets. Pre-ACTH cortisol provided no additional diagnostic value when post-ACTH cortisol was known. CONCLUSION: Basal cortisol >55 nmol/L is a reliable rule-out test for canine HA in both referral and first-opinion settings, at prevalences lower than seen in referral practices. However, when an ACTH stimulation test is conducted, post-ACTH cortisol alone provides perfect diagnostic accuracy, rendering pre-ACTH cortisol redundant. These findings support omitting pre-ACTH cortisol in routine ACTH stimulation testing to streamline diagnostics and reduce costs without compromising diagnostic performance.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/41180238/